Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2012, Article ID 414128, 8 pages
http://dx.doi.org/10.1155/2012/414128
Review Article

Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney

Pediatric Nephrology Unit, Department of Pediatrics, Federal University of Minas Gerais (UFMG), 30130-100 Belo Horizonte MG, Brazil

Received 1 September 2011; Accepted 2 November 2011

Academic Editor: Robson Santos

Copyright © 2012 Sergio Veloso Brant Pinheiro and Ana Cristina Simões e Silva. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. T. Schiavone, R. A. S. Santos, K. B. Brosnihan, M. C. Khosla, and C. M. Ferrario, “Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1–7) heptapeptide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 11, pp. 4095–4098, 1988. View at Google Scholar · View at Scopus
  2. R. A. S. Santos, A. J. Ferreira, and A. C. Simões e Silva, “Recent advances in the angiotensin-converting enzyme 2-angiotensin(1–7)-Mas axis,” Experimental Physiology, vol. 93, no. 5, pp. 519–527, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. M. Iwai and M. Horiuchi, “Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1–7)-Mas receptor axis,” Hypertension Research, vol. 32, no. 7, pp. 533–536, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. M. Donoghue, F. Hsieh, E. Baronas et al., “A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9,” Circulation research, vol. 87, no. 5, pp. E1–E9, 2000. View at Google Scholar · View at Scopus
  5. S. R. Tipnis, N. M. Hooper, R. Hyde, E. Karran, G. Christie, and A. J. Turner, “A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase,” Journal of Biological Chemistry, vol. 275, no. 43, pp. 33238–33243, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. G. I. Rice, D. A. Thomas, P. J. Grant, A. J. Turner, and N. M. Hooper, “Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism,” Biochemical Journal, vol. 383, part 1, pp. 45–51, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. C. Vickers, P. Hales, V. Kaushik et al., “Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase,” Journal of Biological Chemistry, vol. 277, no. 17, pp. 14838–14843, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. M. C. Chappell, N. T. Pirro, A. Sykes, and C. M. Ferrario, “Metabolism of angiotensin-(1–7) by angiotensin-converting enzyme,” Hypertension, vol. 31, no. 1, part 2, pp. 362–367, 1998. View at Google Scholar · View at Scopus
  9. L. Stanziola, L. J. Greene, and R. A. S. Santos, “Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats,” American Journal of Hypertension, vol. 12, no. 10, part 1, pp. 1021–1029, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. D. J. Campbell, C. J. Zeitz, M. D. Esler, and J. D. Horowitz, “Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation,” Journal of Hypertension, vol. 22, no. 10, pp. 1971–1976, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. R. A. S. Santos, A. C. Simoes e Silva, C. Maric et al., “Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8258–8263, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. R. A. S. Santos, M. J. Campagnole-Santos, N. C. V. Baracho et al., “Characterization of a new angiotensin antagonist selective for angiotensin-(1–7): evidence that the actions of angiotensin-(1–7) are mediated by specific angiotensin receptors,” Brain Research Bulletin, vol. 35, no. 4, pp. 293–298, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Ambühl, D. Felix, and M. C. Khosla, “[7-D-Ala]-angiotensin-(1–7): selective antagonism of angiotensin-(1–7) in the rat paraventricular nucleus,” Brain Research Bulletin, vol. 35, no. 4, pp. 289–291, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. A. J. Ferreira, R. A. S. Santos, C. N. Bradford et al., “Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases,” Hypertension, vol. 55, no. 2, pp. 207–213, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. M. C. Chappell, J. Gregory Modralt, D. I. Diz, and C. M. Ferrario, “Novel aspects of the renal renin-angiotensin system: angiotensin-(1–7),ACE2 and blood pressure regulation,” Contributions to Nephrology, vol. 143, pp. 77–89, 2004. View at Google Scholar · View at Scopus
  16. A. J. Allred, M. C. Chappell, C. M. Ferrario, and D. I. Diz, “Differential actions of renal ischemic injury on the intrarenal angiotensin system,” American Journal of Physiology—Renal Physiology, vol. 279, no. 4, pp. F636–F645, 2000. View at Google Scholar · View at Scopus
  17. M. C. Chappell, A. J. Allred, and C. M. Ferrario, “Pathways of angiotensin-(1–7) metabolism in the kidney,” Nephrology Dialysis Transplantation, vol. 16, no. 1, pp. 22–26, 2001. View at Google Scholar · View at Scopus
  18. H. Ji, S. Menini, W. Zheng, C. Pesce, X. Wu, and K. Sandberg, “Role of angiotensin-converting enzyme 2 and angiotensin(1–7) in 17β-oestradiol regulation of renal pathology in renal wrap hypertension in rats,” Experimental Physiology, vol. 93, no. 5, pp. 648–657, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. J. Liu, H. Ji, W. Zheng et al., “Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17b-oestradioldependent and sex chromosome-independent,” Biology of Sex Differences, vol. 1, no. 1, p. 6, 2010. View at Google Scholar
  20. C. M. Ferrario, R. D. Smith, B. Brosnihan et al., “Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension,” American Journal of Hypertension, vol. 15, no. 6, pp. 557–564, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. C. M. Ferrario, J. Jessup, P. E. Gallagher et al., “Effects of renin-angiotensin system blockade on renal angiotensin-(1–7) forming enzymes and receptors,” Kidney International, vol. 68, no. 5, pp. 2189–2196, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. A. C. Simoes-e-Silva, N. C. V. Baracho, K. T. Passaglio, and R. A. S. Santos, “Renal actions of angiotensin-(1–7),” Brazilian Journal of Medical and Biological Research, vol. 30, no. 4, pp. 503–513, 1997. View at Google Scholar · View at Scopus
  23. R. A. S. Santos, K. T. Passaglio, J. B. Pesquero, M. Bader, and A. C. Simões e Silva, “Interactions between angiotensin-(1–7), kinins, and angiotensin II in kidney and blood vessels,” Hypertension, vol. 38, no. 3, pp. 660–664, 2001. View at Google Scholar · View at Scopus
  24. R. M. Carey and H. M. Siragy, “Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation,” Endocrine Reviews, vol. 24, no. 3, pp. 261–271, 2003. View at Google Scholar · View at Scopus
  25. C. M. Ferrario and M. C. Chappell, “Novel angiotensin peptides,” Cellular and Molecular Life Sciences, vol. 61, no. 21, pp. 2720–2727, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. A. C. Simões e Silva, S. V. B. Pinheiro, R. M. Pereira, A. J. Ferreira, and R. A. S. Santos, “The therapeutic potential of Angiotensin-(1–7) as a novel Renin-Angiotensin System mediator,” Mini-Reviews in Medicinal Chemistry, vol. 6, no. 5, pp. 603–609, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Andreatta-Van Leyen, M. F. Romero, M. C. Khosla, and J. G. Douglas, “Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1–7),” Kidney International, vol. 44, no. 5, pp. 932–936, 1993. View at Google Scholar · View at Scopus
  28. R. K. Handa, “Angiotensin-(1–7) can interact with the rat proximal tubule AT4 receptor system,” American Journal of Physiology—Renal Physiology, vol. 277, no. 1, part 2, pp. F75–F83, 1999. View at Google Scholar · View at Scopus
  29. L. S. Lara, T. De Carvalho, L. R. Leão-Ferreira, A. G. Lopes, and C. Caruso-Neves, “Modulation of the (Na+K+)ATPase activity by Angiotensin-(1–7) in MDCK cells,” Regulatory Peptides, vol. 129, no. 1–3, pp. 221–226, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. L. S. Lara, F. Cavalcante, F. Axelband, A. M. De Souza, A. G. Lopes, and C. Caruso-Neves, “Involvement of the Gi/o/cGMP/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1–7),” Biochemical Journal, vol. 395, no. 1, pp. 183–190, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. A. M. DelliPizzi, S. D. Hilchey, and C. P. Bell-Quilley, “Natriuretic action of angiotensin(1–7),” British Journal of Pharmacology, vol. 111, no. 1, pp. 1–3, 1994. View at Google Scholar · View at Scopus
  32. V. Vallon, K. Richter, N. Heyne, and H. Osswald, “Effect of intratubular application of angiotensin 1–7 on nephron function,” Kidney and Blood Pressure Research, vol. 20, no. 4, pp. 233–239, 1997. View at Google Scholar · View at Scopus
  33. M. G. López Ordieres, M. Gironacci, G. Rodríguez de Lores Arnaiz, and C. Peñ, “Effect of angiotensin-(1–7) on ATPase activities in several tissues,” Regulatory Peptides, vol. 77, no. 1–3, pp. 135–139, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Bürgelová, H. J. Kramer, V. Teplan et al., “Intrarenal infusion of angiotensin-(1–7) modulates renal functional responses to exogenous angiotensin II in the rat,” Kidney and Blood Pressure Research, vol. 25, no. 4, pp. 202–210, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. S. V. B. Pinheiro, A. C. Simões e Silva, W. O. Sampaio et al., “Nonpeptide AVE 0991 is an angiotensin-(1–7) receptor mas agonist in the mouse kidney,” Hypertension, vol. 44, no. 4, pp. 490–496, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. R. A. S. Santos and N. C. V. Baracho, “Angiotensin-(1–7) is a potent antidiuretic peptide in rats,” Brazilian Journal of Medical and Biological Research, vol. 25, no. 6, pp. 651–654, 1992. View at Google Scholar · View at Scopus
  37. N. H. Garcia and J. L. Garvin, “Angiotensin 1–7 has a biphasic effect on fluid absorption in the proximal straight tubule,” Journal of the American Society of Nephrology, vol. 5, no. 4, pp. 1133–1138, 1994. View at Google Scholar · View at Scopus
  38. R. A. S. Santos, A. C. Simões e Silva, A. J. Magaldi et al., “Evidence for a physiological role of angiotensin-(1–7) in the control of hydroelectrolyte balance,” Hypertension, vol. 27, no. 4, pp. 875–884, 1996. View at Google Scholar · View at Scopus
  39. N. C. V. Baracho, A. C. Simões e Silva, M. C. Khosla, and R. A. S. Santos, “Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1–7) in water-loaded rats,” Brazilian Journal of Medical and Biological Research, vol. 31, no. 9, pp. 1221–1227, 1998. View at Google Scholar · View at Scopus
  40. A. C. Simões e Silva, A. P. C. Bello, N. C. V. Baracho, M. C. Khosla, and R. A. S. Santos, “Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1–7) antagonist in normotensive and hypertensive rats,” Regulatory Peptides, vol. 74, no. 2-3, pp. 177–184, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. A. J. Magaldi, K. R. Cesar, M. de Araújo, A. C. Simões e Silva, and R. A. S. Santos, “Angiotensin-(1–7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors,” Pflugers Archiv European Journal of Physiology, vol. 447, no. 2, pp. 223–230, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. R. A. S. Santos, A. S. Haibara, M. J. Campagnole-Santos et al., “Characterization of a new selective antagonist for angiotensin-(1–7), D-pro7-angiotensin-(1–7),” Hypertension, vol. 41, no. 3, part 2, pp. 737–743, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. A. J. Ferreira, S. V. B. Pinheiro, C. H. Castro et al., “Renal function in transgenic rats expressing an angiotensin-(1–7)-producing fusion protein,” Regulatory Peptides, vol. 137, no. 3, pp. 128–133, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. L. G. Navar and A. Nishiyama, “Why are angiotensin concentrations so high in the kidney?” Current Opinion in Nephrology and Hypertension, vol. 13, no. 1, pp. 107–115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. U. C. Brewster and M. A. Perazella, “The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease,” American Journal of Medicine, vol. 116, no. 4, pp. 263–272, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. E. A. Jaimes, R. X. Tian, D. Pearse, and L. Raij, “Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species,” Kidney International, vol. 68, no. 5, pp. 2143–2153, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. Y. Ren, J. L. Garvin, and O. A. Carretero, “Vasodilator action of angiotensin-(1–7) on isolated rabbit afferent arterioles,” Hypertension, vol. 39, no. 3, pp. 799–802, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. W. O. Sampaio, A. A. S. Nascimento, and R. A. S. Santos, “Systemic and regional hemodynamic effects of angiotensin-(1–7) in rats,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 284, no. 6, pp. H1985–H1994, 2003. View at Google Scholar · View at Scopus
  49. J. Stegbauer, V. Oberhauser, O. Vonend, and L. C. Rump, “Angiotensin-(1–7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats,” Cardiovascular Research, vol. 61, no. 2, pp. 352–359, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. R. A. S. Santos, C. H. Castro, E. Gava et al., “Impairment of in vitro and in vivo heart function in angiotensin-(1–7) receptor mas knockout mice,” Hypertension, vol. 47, no. 5, pp. 996–1002, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. R. M. Pereira, R. A. S. Santos, M. M. Teixeira et al., “The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of Angiotensin-(1–7),” Journal of Hepatology, vol. 46, no. 4, pp. 674–681, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. S. V. B. Pinheiro, A. J. Ferreira, G. T. Kitten et al., “Genetic deletion of the angiotensin-(1–7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria,” Kidney International, vol. 75, no. 11, pp. 1184–1193, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. G. S. Kuncio, E. G. Neilson, and T. Haverty, “Mechanisms of tubulointerstitial fibrosis,” Kidney International, vol. 39, no. 3, pp. 550–556, 1991. View at Google Scholar · View at Scopus
  54. R. C. Harris and E. G. Neilson, “Toward a unified theory of renal progression,” Annual Review of Medicine, vol. 57, pp. 365–380, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. J. Zhang, N. A. Noble, W. A. Border, and Y. Huang, “Infusion of angiotensin-(1–7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis,” American Journal of Physiology—Renal Physiology, vol. 298, no. 3, pp. F579–F588, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. E. A. Tallant and M. A. Clark, “Molecular mechanisms of inhibition of vascular growth by angiotensin-(1–7),” Hypertension, vol. 42, no. 4, pp. 574–579, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. E. A. Tallant, C. M. Ferrario, and P. E. Gallagher, “Angiotensin-(1–7) inhibits growth of cardiac myocytes through activation of the mas receptor,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 289, no. 4, pp. H1560–H1566, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. M. Iwata, R. T. Cowling, D. Gurantz et al., “Angiotensin-(1–7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 289, no. 6, pp. H2356–H2363, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. P. E. Gallagher and E. A. Tallant, “Inhibition of human lung cancer cell growth by angiotensin-(1–7),” Carcinogenesis, vol. 25, no. 11, pp. 2045–2052, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. Z. Su, J. Zimpelmann, and K. D. Burns, “Angiotensin-(1–7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells,” Kidney International, vol. 69, no. 12, pp. 2212–2218, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. G. Y. Oudit, A. M. Herzenberg, Z. Kassiri et al., “Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis,” American Journal of Pathology, vol. 168, no. 6, pp. 1808–1820, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. J. Wysocki, M. Ye, M. J. Soler et al., “ACE and ACE2 activity in diabetic mice,” Diabetes, vol. 55, no. 7, pp. 2132–2139, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. M. Ye, J. Wysocki, J. William, M. J. Soler, I. Cokic, and D. Batlle, “Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes,” Journal of the American Society of Nephrology, vol. 17, no. 11, pp. 3067–3075, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. D. W. Wong, G. Y. Oudit, H. Reich et al., “Loss of Angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury,” American Journal of Pathology, vol. 171, no. 2, pp. 438–451, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. M. J. Soler, J. Wysocki, M. Ye, J. Lloveras, Y. Kanwar, and D. Batlle, “ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice,” Kidney International, vol. 72, no. 5, pp. 614–623, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. M. Dilauro, J. Zimpelmann, S. J. Robertson, D. Genest, and K. D. Burns, “Effect of ACE2 and angiotensin-(1–7) in a mouse model of early chronic kidney disease,” American Journal of Physiology—Renal Physiology, vol. 298, no. 6, pp. F1523–F1532, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. K. D. Silveira, K. S. Pompermayer Bosco, L. R. L. Diniz et al., “ACE2-angiotensin-(1–7)-Mas axis in renal ischaemia/reperfusion injury in rats,” Clinical Science, vol. 119, no. 9, pp. 385–394, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. C. M. Ferrario, “ACE2: more of Ang-(1–7) or less Ang II?” Current Opinion in Nephrology and Hypertension, vol. 20, no. 1, pp. 1–6, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. R. A. S. Santos, A. J. Ferreira, and A. C. Simões e Silva, “Angiotensins,” in Cardiovascular Hormone Systems: From Molecular Mechanisms to Novel Therapeutics, M. Bader, Ed., pp. 67–100, Wiley-VCH, Weinheim, Germany, 1 edition, 2008. View at Google Scholar
  70. A. C. Simões E Silva and J. T. Flynn, “The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease,” Pediatric Nephrology. In press. View at Publisher · View at Google Scholar · View at PubMed
  71. V. Esteban, S. Heringer-Walther, A. Sterner-Kock et al., “Angiotensin-(1–7) and the G protein-coupled receptor Mas are key players in renal inflammation,” PLoS ONE, vol. 4, no. 4, Article ID e5406, 2009. View at Publisher · View at Google Scholar · View at PubMed
  72. E. Velkoska, R. G. Dean, K. Griggs, L. Burchill, and L. M. Burrell, “Angiotensin-(1–7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy,” Clinical Science, vol. 120, no. 8, pp. 335–345, 2011. View at Publisher · View at Google Scholar · View at PubMed
  73. J. Zimpelmann and K. D. Burns, “Angiotensin-(1–7) activates growth-stimulatory pathways in human mesangial cells,” American Journal of Physiology—Renal Physiology, vol. 296, no. 2, pp. F337–F346, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. E. A. van der Wouden, P. Ochodnický, R. P. Van Dokkum et al., “The role of angiotensin(1–7) in renal vasculature of the rat,” Journal of Hypertension, vol. 24, no. 10, pp. 1971–1978, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. S. Mizuiri, H. Hemmi, M. Arita et al., “Increased ACE and decreased ACE2 expression in kidneys from patients with IgA nephropathy,” Nephron—Clinical Practice, vol. 117, no. 1, pp. c57–c66, 2010. View at Publisher · View at Google Scholar · View at PubMed
  76. A. C. Simões e Silva, J. S. S. Diniz, R. M. Pereira, S. V. B. Pinheiro, and R. A. S. Santos, “Circulating renin angiotensin system in childhood chronic renal failure: marked increase of angiotensin-(1–7) in end-stage renal disease,” Pediatric Research, vol. 60, no. 6, pp. 734–739, 2006. View at Publisher · View at Google Scholar · View at PubMed
  77. M. Luque, P. Martin, N. Martell, C. Fernandez, K. B. Brosnihan, and C. M. Ferrario, “Effects of captopril related to increased levels of prostacyclin and angiotensin-(1–7) in essential hypertension,” Journal of Hypertension, vol. 14, no. 6, pp. 799–805, 1996. View at Publisher · View at Google Scholar
  78. M. Azizi and J. Ménard, “Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists,” Circulation, vol. 109, no. 21, pp. 2492–2499, 2004. View at Publisher · View at Google Scholar · View at PubMed
  79. M. J. A. Kocks, A. T. Lely, F. Boomsma, P. E. de Jong, and G. Navis, “Sodium status and angiotensin-converting enzyme inhibition: effects on plasma angiotensin-(1–7) in healthy man,” Journal of Hypertension, vol. 23, no. 3, pp. 597–602, 2005. View at Google Scholar
  80. M. W. Taal and B. M. Brenner, “Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists,” Kidney International, vol. 57, no. 5, pp. 1803–1817, 2000. View at Publisher · View at Google Scholar · View at PubMed
  81. I. Codreanu, N. Perico, and G. Remuzzi, “Dual blockade of the renin-angiotensin system: the ultimate treatment for renal protection?” Journal of the American Society of Nephrology, vol. 16, no. 3, pp. S34–S38, 2005. View at Publisher · View at Google Scholar
  82. C. M. Ferrario, N. Martell, C. Yunis et al., “Characterization of angeotensin-(1–7) in the urine of normal and essential hypertensive subjects,” American Journal of Hypertension, vol. 11, no. 2, pp. 137–146, 1998. View at Publisher · View at Google Scholar
  83. A. C. Simões e Silva, J. S. S. Diniz, A. Regueira Filho, and R. A. S. Santos, “The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1–7) in essential hypertension,” Journal of Pediatrics, vol. 145, no. 1, pp. 93–98, 2004. View at Publisher · View at Google Scholar · View at PubMed